GLP-1 medications like semaglutide and tirzepatide have exploded in popularity, with millions of Americans turning to them for weight loss. But are they the magic bullet for sustainable results? The ...

The diabetes and weight loss drugs are “not cost-effective at their current prices, and are largely unavailable to people with lower incomes,” the report said.

Former FDA Commissioner David Kessler shared his experience with GLP-1 weight loss drugs on "CBS Mornings Plus." ...

Orlistat (sold as Alli) is one effective over-the-counter weight loss aid that is also FDA-approved.

Digital programs incorporating behavioral therapy led to solid reductions in body weight, and did so at lower drug doses.

Prescription drug spending in the United States rose by 10.2% last year, thanks in part to the popularity of GLP weight-loss ...

While the drugs certainly contribute to weight loss and health gains, they also cause a decline in muscle that some doctors ...

New research being presented at the European Congress on Obesity (ECO 2025) has found that patients of an online obesity ...

Weight-loss injections, or GLP-1 receptor agonists, could nearly halve the risk of obesity-related cancers, a new study finds ...

While GLP-1 receptor agonists and bariatric surgery offer significant metabolic benefits, experts caution that rapid weight ...

The U.S. Food and Drug Administration (FDA) has issued a warning to patients and healthcare professionals regarding the use ...